Detailed View
CAPR - Capricor Therapeutics, Inc.
Latest filing: 2026-06-30 | Reporting: gaap
Market Cap
397,380,000
Adj EBIT (TTM)
-135,158,521
Enterprise Value
376,444,813
Last Price
6.83
Earnings Yield
-35.90%
Return on Capital
-40.25%
Capital
335,774,414
1Y Price Chart
Last Price: -
1Y Change: -
Company Summary
Loading summary...
| endDate | formType | fiscalYear | Revenue | OperatingIncomeLoss |
|---|---|---|---|---|
| 2026-06-30 | 10-Q | 2026 | 0 | -42,945,620 |
| 2026-03-31 | 10-Q | 2026 | 0 | -36,772,853 |
| 2025-12-31 | 10-K (Q4 derived) | 2025 | -24,925,148 | -29,156,008 |
| 2025-09-30 | 10-Q | 2025 | 2,261,641 | -26,284,040 |
| 2025-06-30 | 10-Q | 2025 | 3,971,438 | -27,719,134 |
| 2025-03-31 | 10-Q | 2025 | 4,906,877 | -24,982,948 |
| 2024-12-31 | 10-K (Q4 derived) | 2024 | 11,130,508 | -7,697,841 |
| 2024-09-30 | 10-Q | 2024 | 2,261,642 | -13,009,880 |
Notice something wrong?
Submit a quick report with a snapshot of the values you are seeing.